Condition: Pseudomonas Infections · Pseudomonas Septicemia · Pseudomonas; Pneumonia · Sponsor: University of Ulm
The present study focuses on patients with Pseudomonas aeruginosa (PSA) sepsis. The aim of the present study is to find out whether the M1 (pro-inflammatory) or M2 (anti-inflammatory) phenotype predominates in blood monocytes in critically ill patients with PSA-sepsis, and whether the severity of sepsis and outcome is associated with distinct monocyte phenotype and function.
This description comes directly from the study's public registry record.
Manfred Weiss, MD, MBA · +49 731 500 60226 · manfred.weiss@uniklinik-ulm.de
Eberhard Barth, MD · +49 731 500 60050 · eberhard.barth@uniklinik-ulm.de
Always discuss trial participation with your own doctor first.
| Clinic of Anesthesiology | Ulm, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03044223